| Dr Edward Michael Galiczynski Jr, DO | |
|
11640 Northpark Dr Ste 200, Wake Forest, NC 27587-5741 | |
| (919) 436-4124 | |
| (919) 439-9645 |
| Full Name | Dr Edward Michael Galiczynski Jr |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 18 Years |
| Location | 11640 Northpark Dr Ste 200, Wake Forest, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255517041 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 2024-00253 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Center For Dermatology Pllc | 1557355385 | 63 |
| Arizona Skin And Laser Therapy Institute Ltd | 6204720626 | 13 |
News Archive
Would banning ventilated filters on cigarettes protect public health? Scientists from multiple institutions, including a group of addiction neuroscience researchers from the Virginia Tech Carilion Research Institute, are gathering evidence under funding from the National Institutes of Health's National Cancer Institute to potentially inform a U.S. Food and Drug Administration (FDA) decision about whether to recommend design changes to filtered cigarettes.
The University of Texas at Arlington and Thermo Fisher Scientific Inc., the world leader in serving science, announced that they have been granted a United States patent (#8,293,099) for a novel charge detector for ion chromatography that they developed together.
New York City officials on Wednesday said that people living in government-subsidized housing for HIV-positive people will be charged more for rent after the state required that changes be made to the payment formula effective Nov. 1, the New York Times reports.
Novartis announced today that the US Food and Drug Administration has approved Promacta (eltrombopag) for the treatment of children six years and older with chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy. Promacta was approved by the FDA in 2008 for use in adult patients with the same condition.
› Verified 7 days ago
| Entity Name | Arizona Skin And Laser Therapy Institute Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740373257 PECOS PAC ID: 6204720626 Enrollment ID: O20040209000424 |
News Archive
Would banning ventilated filters on cigarettes protect public health? Scientists from multiple institutions, including a group of addiction neuroscience researchers from the Virginia Tech Carilion Research Institute, are gathering evidence under funding from the National Institutes of Health's National Cancer Institute to potentially inform a U.S. Food and Drug Administration (FDA) decision about whether to recommend design changes to filtered cigarettes.
The University of Texas at Arlington and Thermo Fisher Scientific Inc., the world leader in serving science, announced that they have been granted a United States patent (#8,293,099) for a novel charge detector for ion chromatography that they developed together.
New York City officials on Wednesday said that people living in government-subsidized housing for HIV-positive people will be charged more for rent after the state required that changes be made to the payment formula effective Nov. 1, the New York Times reports.
Novartis announced today that the US Food and Drug Administration has approved Promacta (eltrombopag) for the treatment of children six years and older with chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy. Promacta was approved by the FDA in 2008 for use in adult patients with the same condition.
› Verified 7 days ago
| Entity Name | Center For Dermatology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194792416 PECOS PAC ID: 1557355385 Enrollment ID: O20040413001574 |
News Archive
Would banning ventilated filters on cigarettes protect public health? Scientists from multiple institutions, including a group of addiction neuroscience researchers from the Virginia Tech Carilion Research Institute, are gathering evidence under funding from the National Institutes of Health's National Cancer Institute to potentially inform a U.S. Food and Drug Administration (FDA) decision about whether to recommend design changes to filtered cigarettes.
The University of Texas at Arlington and Thermo Fisher Scientific Inc., the world leader in serving science, announced that they have been granted a United States patent (#8,293,099) for a novel charge detector for ion chromatography that they developed together.
New York City officials on Wednesday said that people living in government-subsidized housing for HIV-positive people will be charged more for rent after the state required that changes be made to the payment formula effective Nov. 1, the New York Times reports.
Novartis announced today that the US Food and Drug Administration has approved Promacta (eltrombopag) for the treatment of children six years and older with chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy. Promacta was approved by the FDA in 2008 for use in adult patients with the same condition.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Edward Michael Galiczynski Jr, DO 2224 W Northern Ave Ste D300, Phoenix, AZ 85021-5099 Ph: (602) 277-1449 | Dr Edward Michael Galiczynski Jr, DO 11640 Northpark Dr Ste 200, Wake Forest, NC 27587-5741 Ph: (919) 436-4124 |
News Archive
Would banning ventilated filters on cigarettes protect public health? Scientists from multiple institutions, including a group of addiction neuroscience researchers from the Virginia Tech Carilion Research Institute, are gathering evidence under funding from the National Institutes of Health's National Cancer Institute to potentially inform a U.S. Food and Drug Administration (FDA) decision about whether to recommend design changes to filtered cigarettes.
The University of Texas at Arlington and Thermo Fisher Scientific Inc., the world leader in serving science, announced that they have been granted a United States patent (#8,293,099) for a novel charge detector for ion chromatography that they developed together.
New York City officials on Wednesday said that people living in government-subsidized housing for HIV-positive people will be charged more for rent after the state required that changes be made to the payment formula effective Nov. 1, the New York Times reports.
Novartis announced today that the US Food and Drug Administration has approved Promacta (eltrombopag) for the treatment of children six years and older with chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy. Promacta was approved by the FDA in 2008 for use in adult patients with the same condition.
› Verified 7 days ago
Elias Emile Ayli, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 110 Capcom Ave Ste 103, Wake Forest, NC 27587 Phone: 919-436-4124 |